Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Stake Lowered by Forza Wealth Management LLC

Forza Wealth Management LLC decreased its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 31.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 13,555 shares of the pharmacy operator’s stock after selling 6,158 shares during the quarter. Forza Wealth Management LLC’s holdings in Walgreens Boots Alliance were worth $126,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently added to or reduced their stakes in WBA. Moody National Bank Trust Division lifted its stake in shares of Walgreens Boots Alliance by 17.6% in the fourth quarter. Moody National Bank Trust Division now owns 32,026 shares of the pharmacy operator’s stock worth $299,000 after buying an additional 4,782 shares during the last quarter. Czech National Bank boosted its holdings in Walgreens Boots Alliance by 6.6% during the fourth quarter. Czech National Bank now owns 155,625 shares of the pharmacy operator’s stock valued at $1,452,000 after acquiring an additional 9,663 shares during the period. Atlas Brown Inc. grew its position in shares of Walgreens Boots Alliance by 77.6% in the fourth quarter. Atlas Brown Inc. now owns 38,240 shares of the pharmacy operator’s stock valued at $357,000 after purchasing an additional 16,710 shares during the last quarter. A. D. Beadell Investment Counsel Inc. bought a new position in shares of Walgreens Boots Alliance in the fourth quarter worth about $93,000. Finally, Regent Peak Wealth Advisors LLC acquired a new position in shares of Walgreens Boots Alliance during the 4th quarter worth about $125,000. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Walgreens Boots Alliance Trading Down 0.9 %

NASDAQ:WBA traded down $0.10 during mid-day trading on Monday, hitting $11.66. The company had a trading volume of 23,596,607 shares, compared to its average volume of 31,691,166. The firm has a market cap of $10.07 billion, a P/E ratio of -1.16, a P/E/G ratio of 1.36 and a beta of 0.64. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $23.76. The business’s fifty day moving average is $9.26 and its two-hundred day moving average is $9.81. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The business had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. During the same quarter last year, the firm earned $0.66 EPS. Walgreens Boots Alliance’s quarterly revenue was up 7.6% compared to the same quarter last year. As a group, research analysts expect that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, December 12th. Shareholders of record on Monday, November 18th were issued a $0.25 dividend. The ex-dividend date of this dividend was Monday, November 18th. This represents a $1.00 annualized dividend and a dividend yield of 8.58%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently -9.99%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on WBA shares. UBS Group increased their price objective on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research report on Thursday, October 17th. Truist Financial cut their price objective on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a research report on Monday, October 7th. TD Cowen lowered their price target on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research note on Tuesday, October 22nd. Barclays raised their price objective on Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Wednesday, October 16th. Finally, Bank of America boosted their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research report on Monday. Four analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, Walgreens Boots Alliance presently has an average rating of “Hold” and an average price target of $12.81.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.